Table: begin end state 1 5 non-cytoplasmic 6 32 transmembrane 33 43 cytoplasmic 44 66 transmembrane 67 93 non-cytoplasmic 94 115 transmembrane 116 135 cytoplasmic 136 159 transmembrane 160 165 non-cytoplasmic 166 190 transmembrane 191 209 cytoplasmic 210 231 transmembrane 232 237 non-cytoplasmic 238 256 transmembrane 257 267 cytoplasmic 268 290 transmembrane 291 309 non-cytoplasmic 310 341 transmembrane 342 352 cytoplasmic 353 377 transmembrane 378 392 non-cytoplasmic 393 417 transmembrane 418 426 cytoplasmic
Input: >SM_b20297 MATLFGGWFALLIAGMPVGFTLIVAALAYMLWQGTGLNFAGQRMIAGLNSFPLLAVPFFI LTAQLMNLSGVTERIFDFAKALVGHIRGGLGHVNIMASVLFSGMSGSAVADAAGLGQLEI KAMRDAGYDEQFSGSITAASAIIGPLIPPSIPLVVYGVIANTSIGGLFLGGIVPGLLCAA SLMIMVYVIAWRRNYATAQRAGFRRVWSTFWHALLPLITPFIIIGGIFAGVFSPTEAAVV AASYALFLGVVVYREITFAKLVTVLRETVSHTAAVGLLIMGVSLFGYVIAREQVPQHVAT FFLTYAEDPLTFLILVNLMLLALGTFIEALAILLLIVPVLVPTALQFGVDPVHFGVMVVF NLMIGILTPPMGVALFVVSKVADIPFGVLARGILPLLIPLVVVLVLITIFPALVTFIPDQ MLGAAR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server